Mario Gabelli Catalent, Inc. Transaction History
Gamco Investors, Inc. Et Al
- $8.56 Billion
- Q2 2024
A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Catalent, Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 26,600 shares of CTLT stock, worth $1.56 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
26,600
Previous 25,300
5.14%
Holding current value
$1.56 Million
Previous $1.43 Million
4.69%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding CTLT
# of Institutions
486Shares Held
160MCall Options Held
364KPut Options Held
837K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.19 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$898 Million0.02% of portfolio
-
Nomura Holdings Inc Tokyo, M011MShares$643 Million1.22% of portfolio
-
State Street Corp Boston, MA7.34MShares$429 Million0.02% of portfolio
-
Barclays PLC London, X04.97MShares$290 Million0.09% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.5B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...